Good
Mostly Aligned
Patient Risk:
Low
Summary
The evaluation correctly identifies that claims 1 and 3 are supported by the label, claim 2 is partially supported, and claims 4 and 5 are not documented in the supplied label data. Important safety-related content in the full labeling is not addressed in the evaluated claims.
Category Scores
Accurate Statements
Linezolid is a prescription antibiotic.
Label indicates linezolid as a synthetic antibacterial agent and marks packaging as 'Rx only' (Sections 11, 12.4).
Linezolid usually comes in 600 mg tablets or capsules.
Label lists a 600 mg Tablet form (ZYVOX 600 mg Tablet). No capsule dosage form is described in the label excerpt.
Linezolid is sold under the brand name Zyvox.
Label uses the brand Zyvox for linezolid products (Sections 11, 12.4).
Unsupported Statements
The generic version is often just 'linezolid'.
No information about generic naming is provided in the supplied label sections.
The generic version is usually cheaper than the brand name.
No pricing or cost information is provided in the supplied label sections.
Contradictions
Important Omissions
Serotonin syndrome risk with concomitant serotonergic or MAO inhibitor drugs
Importance:
Moderate
Myelosuppression (thrombocytopenia, anemia) with prolonged use
Importance:
Moderate
Peripheral and optic neuropathy and lactic acidosis risk with extended use
Importance:
Moderate
Pregnancy risk
Importance:
Moderate
Pediatric safety and dosing specifics
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The evaluated claims do not introduce new patient safety risks but omit critical safety content present in the full label (boxed warnings, contraindications, and population-specific safety).
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Missing safety content and use-in-populations details; no information on boxed warnings, contraindications, interactions, or dosing safety beyond the 600 mg tablet form.
Suggested Improvement
Incorporate FDA-labeled indications, complete dosing guidance, contraindications, boxed warnings, warnings/precautions, drug interactions, use in special populations (pregnancy, pediatric), administration instructions, and storage/handling details; confirm generic naming information if applicable.